SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-257383
Filing Date
2024-11-13
Accepted
2024-11-13 17:26:01
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 d856300ds3.htm S-3 506037
2 EX-1.2 d856300dex12.htm EX-1.2 183310
3 EX-4.6 d856300dex46.htm EX-4.6 290682
4 EX-4.8 d856300dex48.htm EX-4.8 94390
5 EX-4.9 d856300dex49.htm EX-4.9 96480
6 EX-4.10 d856300dex410.htm EX-4.10 85111
7 EX-5.1 d856300dex51.htm EX-5.1 28027
8 EX-23.1 d856300dex231.htm EX-23.1 1801
9 EX-23.2 d856300dex232.htm EX-23.2 1609
10 EX-23.3 d856300dex233.htm EX-23.3 1973
11 EX-FILING FEES d856300dexfilingfees.htm EX-FILING FEES 52556
12 GRAPHIC g856300g1109065839550.jpg GRAPHIC 2409
13 GRAPHIC g856300g22k01.jpg GRAPHIC 33763
  Complete submission text file 0001193125-24-257383.txt   1392877
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-871-4300
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

IRS No.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283209 | Film No.: 241455786
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)